Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
Aarhus University Hospital · Steno Diabetes Center · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
138
total citations
- FWCI
- 42.86
- Percentile
- 100%
- References
- 35
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Medicine
- Semaglutide
- Prediabetes
- Placebo
- Double blind
- Physical therapy
- Internal medicine
- Diabetes mellitus
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.